Strider identifies more than 6,000 joint publications and collaborations between researchers from 80 Australian organisations and Chinese government linked institutions…
IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached with no dose-limiting toxicities observed. TLX101-Tx is also…
Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights First Dave & Buster’s location in Australia…
Dave & Buster’s makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights First Dave & Buster’s location in Australia…
SYDNEY, May 18, 2026 /PRNewswire/ — BenQ Australia, today announced two new products that together deliver a complete, meeting room…
RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date. Dr. Coulie brings…
Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced…
MELBOURNE, Australia, May 15, 2026 /PRNewswire/ — Lydsec Keypasco Digital Technology Company recently announced a successful partnership with its Australian…
SYDNEY, May 15, 2026 /PRNewswire/ — BenQ is set to showcase the brand-new BenQ Board Pro RP05 and BenQ Board Master…
NeuroEndocrine Cancer Australia (NECA) has launched a fully updated digital platform designed to improve how the 31,000 Australians affected by…
